ArticleiScience2024

CircZCCHC2 decreases pirarubicin sensitivity and promotes triple-negative breast cancer development via the miR-1200/TPR axis.

Fan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.